Schizophrenia, antipsychotics and metabolic disease.
Reynolds
Gavin P
GP
D014150:Antipsychotic Agents / Q000009:adverse effects* / Q000627:therapeutic use; D002318:Cardiovascular Diseases / Q000139:chemically induced; D003924:Diabetes Mellitus, Type 2 / Q000139:chemically induced; D006801:Humans; D006949:Hyperlipidemias / Q000139:chemically induced; D024821:Metabolic Syndrome / Q000139:chemically induced* / Q000209:etiology; D009765:Obesity / Q000139:chemically induced; D012307:Risk Factors; D012559:Schizophrenia / Q000150:complications / Q000188:drug therapy*; D015430:Weight Gain / Q000187:drug effects
D014150:Antipsychotic Agents